<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Durect Corp.</title><link>https://investorshangout.com/Durect-Corp-DRRX-53933/</link><description><![CDATA[Durect Corp. (DRRX)]]></description><language>en-us</language><pubDate>Sun, 06 Sep 2026 08:15:04 GMT</pubDate><copyright>Copyright InvestorsHangout.com</copyright><atom:link href="https://investorshangout.com/Durect-Corp-DRRX-53933/" rel="self" type="application/rss+xml"/><item><title>MythicSphinx35: Jim Brown CEO stated the following: &quot;The FDA has confirmed that a single pivotal trial would be s</title><link>https://investorshangout.com/post/view?id=6712284</link><guid>https://investorshangout.com/post/view?id=6712284</guid><description><![CDATA[MythicSphinx35
]]></description><pubDate>Wed, 14 Aug 2024 07:31:46 GMT</pubDate></item><item><title>MythicSphinx35: Highlights/Summary of DRRX Conference call: FDA granted Breakthrough Therapy Designation for la</title><link>https://investorshangout.com/post/view?id=6712277</link><guid>https://investorshangout.com/post/view?id=6712277</guid><description><![CDATA[MythicSphinx35
]]></description><pubDate>Wed, 14 Aug 2024 05:58:33 GMT</pubDate></item><item><title>MythicSphinx35: Up 26.67% today! Looks like FDA Breakthrough Therapy Designation (BTD) has created some investor int</title><link>https://investorshangout.com/post/view?id=6697990</link><guid>https://investorshangout.com/post/view?id=6697990</guid><description><![CDATA[MythicSphinx35
]]></description><pubDate>Fri, 31 May 2024 23:10:51 GMT</pubDate></item><item><title>MythicSphinx35: In my opinion the Breakthrough Therapy Designation (BTD) for larsucosterol could indeed increase the</title><link>https://investorshangout.com/post/view?id=6695512</link><guid>https://investorshangout.com/post/view?id=6695512</guid><description><![CDATA[MythicSphinx35
]]></description><pubDate>Wed, 22 May 2024 03:09:10 GMT</pubDate></item><item><title>MythicSphinx35:  DRRX receives Breakthrough Therapy Designation (BTD) from FDA. In my opinion this can result in the</title><link>https://investorshangout.com/post/view?id=6695419</link><guid>https://investorshangout.com/post/view?id=6695419</guid><description><![CDATA[MythicSphinx35
]]></description><pubDate>Tue, 21 May 2024 18:19:38 GMT</pubDate></item><item><title>MythicSphinx35: FDA Update &amp; Key Points: “We are pleased that the feedback from the U.S. Food and Drug Administra</title><link>https://investorshangout.com/post/view?id=6693335</link><guid>https://investorshangout.com/post/view?id=6693335</guid><description><![CDATA[MythicSphinx35
]]></description><pubDate>Mon, 13 May 2024 22:45:51 GMT</pubDate></item><item><title>MythicSphinx35: DUR-928, also known as larsucosterol, is an investigational drug being developed by DURECT Corporati</title><link>https://investorshangout.com/post/view?id=6691078</link><guid>https://investorshangout.com/post/view?id=6691078</guid><description><![CDATA[MythicSphinx35
]]></description><pubDate>Mon, 06 May 2024 03:49:24 GMT</pubDate></item><item><title>MythicSphinx35: Mortality Benefit: The substantial reduction in mortality observed in the US-specific data aligns wi</title><link>https://investorshangout.com/post/view?id=6690924</link><guid>https://investorshangout.com/post/view?id=6690924</guid><description><![CDATA[MythicSphinx35
]]></description><pubDate>Sat, 04 May 2024 22:00:30 GMT</pubDate></item><item><title>MythicSphinx35: By focusing specifically on the significantly improved survival outcomes observed within the U.S. pa</title><link>https://investorshangout.com/post/view?id=6690837</link><guid>https://investorshangout.com/post/view?id=6690837</guid><description><![CDATA[MythicSphinx35
]]></description><pubDate>Sat, 04 May 2024 06:47:01 GMT</pubDate></item><item><title>MythicSphinx35: Deeper Dive into DUR-928 Hypothetical Scenario and Implications: Transplant Counts: Let&#039;s assume th</title><link>https://investorshangout.com/post/view?id=6690625</link><guid>https://investorshangout.com/post/view?id=6690625</guid><description><![CDATA[MythicSphinx35
]]></description><pubDate>Fri, 03 May 2024 16:26:17 GMT</pubDate></item><item><title>MythicSphinx35: Lets assume that liver transplant recipients in the study were categorized as alive instead of decea</title><link>https://investorshangout.com/post/view?id=6690405</link><guid>https://investorshangout.com/post/view?id=6690405</guid><description><![CDATA[MythicSphinx35
]]></description><pubDate>Thu, 02 May 2024 22:24:02 GMT</pubDate></item><item><title>whytestocks: $DRRX News Article - DURECT Corporation to Announce Third Quarter 2023 Financial Results and Provide</title><link>https://investorshangout.com/post/view?id=6642668</link><guid>https://investorshangout.com/post/view?id=6642668</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 09 Nov 2023 21:35:46 GMT</pubDate></item><item><title>whytestocks: $DRRX News Article - Expected earnings - DURECT Corporation </title><link>https://investorshangout.com/post/view?id=6639783</link><guid>https://investorshangout.com/post/view?id=6639783</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 01 Nov 2023 19:45:53 GMT</pubDate></item><item><title>whytestocks: $DRRX News Article - Durect Corp. (NASDAQ: DRRX) Making Surprising Moves in Monday Session </title><link>https://investorshangout.com/post/view?id=6558779</link><guid>https://investorshangout.com/post/view?id=6558779</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 10 Apr 2023 17:05:48 GMT</pubDate></item><item><title>whytestocks: $DRRX News Article - DURECT Reaches Enrollment Milestone in Phase 2b AHFIRM Trial </title><link>https://investorshangout.com/post/view?id=6481552</link><guid>https://investorshangout.com/post/view?id=6481552</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 06 Oct 2022 17:10:50 GMT</pubDate></item><item><title>whytestocks: $DRRX News Article - Innocoll and DURECT Announce U.S. launch of POSIMIR </title><link>https://investorshangout.com/post/view?id=6476207</link><guid>https://investorshangout.com/post/view?id=6476207</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 26 Sep 2022 14:10:52 GMT</pubDate></item><item><title>whytestocks: $DRRX News Article - DURECT Corporation Appoints Timothy M. Papp as Chief Financial Officer </title><link>https://investorshangout.com/post/view?id=6432874</link><guid>https://investorshangout.com/post/view?id=6432874</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 05 Jul 2022 14:55:52 GMT</pubDate></item><item><title>znewcar1: DRRX 32% v2,3M c.55 f227M H.5789 ML.3601</title><link>https://investorshangout.com/post/view?id=6413128</link><guid>https://investorshangout.com/post/view?id=6413128</guid><description><![CDATA[znewcar1
]]></description><pubDate>Tue, 31 May 2022 21:34:50 GMT</pubDate></item><item><title>whytestocks: $DRRX News Article - DURECT Corporation to Present at the H.C. Wainwright Global Investment Conferen</title><link>https://investorshangout.com/post/view?id=6405938</link><guid>https://investorshangout.com/post/view?id=6405938</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 18 May 2022 20:00:50 GMT</pubDate></item><item><title>whytestocks: $DRRX News Article - DURECT Corporation to Announce First Quarter 2022 Financial Results and Provide</title><link>https://investorshangout.com/post/view?id=6391720</link><guid>https://investorshangout.com/post/view?id=6391720</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 27 Apr 2022 20:25:50 GMT</pubDate></item><item><title>whytestocks: $DRRX News Article - DURECT Corporation Fireside Chat at the Oppenheimer 32nd Annual Healthcare Conf</title><link>https://investorshangout.com/post/view?id=6359433</link><guid>https://investorshangout.com/post/view?id=6359433</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 09 Mar 2022 21:35:51 GMT</pubDate></item><item><title>whytestocks: $DRRX News Article - DURECT Corporation Doses First European Patient in Phase 2b AHFIRM Study of Lar</title><link>https://investorshangout.com/post/view?id=6353883</link><guid>https://investorshangout.com/post/view?id=6353883</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 01 Mar 2022 17:35:53 GMT</pubDate></item><item><title>whytestocks: $DRRX News Article - DURECT Corporation Announces U.S. FDA Approval of POSIMIR For Post-Surgical Pa</title><link>https://investorshangout.com/post/view?id=6038497</link><guid>https://investorshangout.com/post/view?id=6038497</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 02 Feb 2021 15:30:49 GMT</pubDate></item><item><title>whytestocks: $DRRX News Article - DURECT Corporation Announces First Patient Dosed in Phase 2b AHFIRM Study of DU</title><link>https://investorshangout.com/post/view?id=6029154</link><guid>https://investorshangout.com/post/view?id=6029154</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 25 Jan 2021 20:50:56 GMT</pubDate></item><item><title>whytestocks: $DRRX News Article - DURECT Corporation Announces Additional Safety Data and Efficacy Signals from P</title><link>https://investorshangout.com/post/view?id=5961989</link><guid>https://investorshangout.com/post/view?id=5961989</guid><description><![CDATA[whytestocks
]]></description><pubDate>Fri, 13 Nov 2020 18:55:47 GMT</pubDate></item><item><title>whytestocks: $DRRX News Article - Durect Corp (DRRX) Q2 2020 Earnings Call Transcript </title><link>https://investorshangout.com/post/view?id=5848609</link><guid>https://investorshangout.com/post/view?id=5848609</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 04 Aug 2020 12:05:47 GMT</pubDate></item><item><title>znewcar1: DRRX 20% v5,3M c2.76 f196M H2.88 S2.55</title><link>https://investorshangout.com/post/view?id=5807019</link><guid>https://investorshangout.com/post/view?id=5807019</guid><description><![CDATA[znewcar1
]]></description><pubDate>Thu, 25 Jun 2020 21:55:54 GMT</pubDate></item><item><title>znewcar1: DRRX 21% v3,4M c2.73 f195,9M H2.86 </title><link>https://investorshangout.com/post/view?id=5765594</link><guid>https://investorshangout.com/post/view?id=5765594</guid><description><![CDATA[znewcar1
]]></description><pubDate>Wed, 13 May 2020 00:12:54 GMT</pubDate></item><item><title>znewcar1: DRRX 19% v3,1M c2.12 f192M H2.18 S2.05</title><link>https://investorshangout.com/post/view?id=5672640</link><guid>https://investorshangout.com/post/view?id=5672640</guid><description><![CDATA[znewcar1
]]></description><pubDate>Wed, 12 Feb 2020 01:56:12 GMT</pubDate></item><item><title>znewcar1: DRRX 23% v3,6M c2.97 f192M H3</title><link>https://investorshangout.com/post/view?id=5626549</link><guid>https://investorshangout.com/post/view?id=5626549</guid><description><![CDATA[znewcar1
]]></description><pubDate>Mon, 23 Dec 2019 21:35:20 GMT</pubDate></item><item><title>BooDog: This puppy might be getting ready to dance soon. Like the potential. </title><link>https://investorshangout.com/post/view?id=5583165</link><guid>https://investorshangout.com/post/view?id=5583165</guid><description><![CDATA[BooDog
]]></description><pubDate>Tue, 05 Nov 2019 13:40:43 GMT</pubDate></item><item><title>whytestocks: $DRRX News Article - DURECT to Present at the 2019 Cantor Fitzgerald Global Health Care Conference </title><link>https://investorshangout.com/post/view?id=5549621</link><guid>https://investorshangout.com/post/view?id=5549621</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 26 Sep 2019 19:25:44 GMT</pubDate></item><item><title>whytestocks: $DRRX News Article - DURECT Announces Positive Data from its Phase 2a Clinical Trial of DUR-928 in A</title><link>https://investorshangout.com/post/view?id=5540902</link><guid>https://investorshangout.com/post/view?id=5540902</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 17 Sep 2019 14:00:44 GMT</pubDate></item><item><title>whytestocks: $DRRX News Article - DURECT Earns $10 Million Milestone Payment for Further Development of a Long-Ac</title><link>https://investorshangout.com/post/view?id=5533681</link><guid>https://investorshangout.com/post/view?id=5533681</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 09 Sep 2019 16:50:44 GMT</pubDate></item><item><title>whytestocks: $DRRX News Article - Morning Stock Trending Alert: DURECT Corporation (NASDAQ:DRRX) </title><link>https://investorshangout.com/post/view?id=5518844</link><guid>https://investorshangout.com/post/view?id=5518844</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 22 Aug 2019 20:40:41 GMT</pubDate></item><item><title>BooDog: 08/02 t 1.25 141400 NDD Wowzers!! Not sure if that was a clearing trade or a single buy</title><link>https://investorshangout.com/post/view?id=5500647</link><guid>https://investorshangout.com/post/view?id=5500647</guid><description><![CDATA[BooDog
]]></description><pubDate>Sat, 03 Aug 2019 16:37:23 GMT</pubDate></item><item><title>whytestocks: $DRRX News Article - DURECT Corporation Announces Second Quarter 2019 Financial Results and Update o</title><link>https://investorshangout.com/post/view?id=5499136</link><guid>https://investorshangout.com/post/view?id=5499136</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 01 Aug 2019 20:15:41 GMT</pubDate></item><item><title>znewcar1: DRRX 33% v13M c.971 f162M H1.05 took four time to get through .9 yet finally did.</title><link>https://investorshangout.com/post/view?id=5489621</link><guid>https://investorshangout.com/post/view?id=5489621</guid><description><![CDATA[znewcar1
]]></description><pubDate>Mon, 22 Jul 2019 20:42:35 GMT</pubDate></item><item><title>BooDog: Under the terms of the agreement, Gilead will make an upfront payment to DURECT of $25 million, with</title><link>https://investorshangout.com/post/view?id=5488880</link><guid>https://investorshangout.com/post/view?id=5488880</guid><description><![CDATA[BooDog
]]></description><pubDate>Mon, 22 Jul 2019 12:37:02 GMT</pubDate></item><item><title>whytestocks: $DRRX News Article - DURECT Announces Completion of the 90 mg Severe Cohort and Dose Escalation Comm</title><link>https://investorshangout.com/post/view?id=5464390</link><guid>https://investorshangout.com/post/view?id=5464390</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 18 Jun 2019 15:31:03 GMT</pubDate></item><item><title>whytestocks: $DRRX News Article - DURECT to Present at the 20th Annual B. Riley FBR Institutional Investor Confer</title><link>https://investorshangout.com/post/view?id=5438934</link><guid>https://investorshangout.com/post/view?id=5438934</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 16 May 2019 20:25:40 GMT</pubDate></item><item><title>znewcar1: DRRX 49% v4,1M c.7899 f162M H.838</title><link>https://investorshangout.com/post/view?id=5428801</link><guid>https://investorshangout.com/post/view?id=5428801</guid><description><![CDATA[znewcar1
]]></description><pubDate>Fri, 03 May 2019 20:25:41 GMT</pubDate></item><item><title>whytestocks: $DRRX News Article - DURECT Corporation to Present Preliminary Data from the Ongoing DUR-928 Alcohol</title><link>https://investorshangout.com/post/view?id=5428655</link><guid>https://investorshangout.com/post/view?id=5428655</guid><description><![CDATA[whytestocks
]]></description><pubDate>Fri, 03 May 2019 17:55:40 GMT</pubDate></item><item><title>znewcar1: 27.52% v1,112,680 c.652900 f162,059,720 strong late morning buying</title><link>https://investorshangout.com/post/view?id=5304554</link><guid>https://investorshangout.com/post/view?id=5304554</guid><description><![CDATA[znewcar1
]]></description><pubDate>Fri, 04 Jan 2019 22:06:11 GMT</pubDate></item><item><title>PoemStone: $DRRX climb gap flag 10 day $2.00 Nasdaq GM </title><link>https://investorshangout.com/post/view?id=5003903</link><guid>https://investorshangout.com/post/view?id=5003903</guid><description><![CDATA[PoemStone
]]></description><pubDate>Sun, 15 Apr 2018 16:49:59 GMT</pubDate></item><item><title>YouLie: Starting to set up nicely</title><link>https://investorshangout.com/post/view?id=3590913</link><guid>https://investorshangout.com/post/view?id=3590913</guid><description><![CDATA[YouLie
]]></description><pubDate>Thu, 03 Mar 2016 03:19:32 GMT</pubDate></item><item><title>danrocks: DRRX Stock is number 167 for the largest percentage gain out of 250 stocks. $DRRX DRRX is up +11.</title><link>https://investorshangout.com/post/view?id=3431736</link><guid>https://investorshangout.com/post/view?id=3431736</guid><description><![CDATA[danrocks
]]></description><pubDate>Sat, 19 Dec 2015 04:11:42 GMT</pubDate></item><item><title>danrocks: DRRX Stock is number 131 for the largest percentage gain out of 250 stocks. $DRRX DRRX is up +9.6</title><link>https://investorshangout.com/post/view?id=3427902</link><guid>https://investorshangout.com/post/view?id=3427902</guid><description><![CDATA[danrocks
]]></description><pubDate>Fri, 18 Dec 2015 01:20:12 GMT</pubDate></item><item><title>clayton: DRRX 2.09 Durect Corp $DRRX stock added to my watch list. Right now with DRRX I am watching the l</title><link>https://investorshangout.com/post/view?id=3415308</link><guid>https://investorshangout.com/post/view?id=3415308</guid><description><![CDATA[clayton
]]></description><pubDate>Mon, 14 Dec 2015 18:25:58 GMT</pubDate></item><item><title>danrocks: DRRX Stock is number 50 for the largest percentage gain out of 250 stocks. $DRRX DRRX is up +16.4</title><link>https://investorshangout.com/post/view?id=2919516</link><guid>https://investorshangout.com/post/view?id=2919516</guid><description><![CDATA[danrocks
]]></description><pubDate>Mon, 04 May 2015 16:57:40 GMT</pubDate></item></channel></rss>